- Home
- PRLD vs DMA Comparison
PRLD vs DMA Comparison
Compare PRLD & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRLD | DMA |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 77.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | DMA |
|---|---|---|
| Price | $2.11 | $8.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 286.6K | 34.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.61 | $4.78 |
| 52 Week High | $4.22 | $8.00 |
Technical Indicators
Market Signals| Indicator | PRLD | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 50.15 | 19.52 |
| Support Level | $1.95 | $8.69 |
| Resistance Level | $2.37 | $8.78 |
| Average True Range (ATR) | 0.21 | 0.14 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 59.65 | 19.23 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.